Tauriga Sciences, Inc. Enhances its Profile on Shopify Platform Through Rewards Program
27 August 2020 - 10:43PM
InvestorsHub NewsWire
Tauriga Sciences,
Inc. Enhances its Profile on Shopify Platform Through Rewards
Program, Real Time Blog, and Multi-Media Customer
Reviews
Optimized
Tauri-Gum™ Search Engine Rankings to Drive Additional Organic
Traffic to E-Commerce Store
NEW YORK, NY --
August 27, 2020 -- InvestoresHub NewsWire -- Tauriga Sciences, Inc.
(OTCQB:
TAUG) (“Tauriga” or the “Company”), a revenue generating,
diversified life sciences company, with a proprietary line of
functional “supplement” chewing gums (Flavors: Pomegranate, Blood
Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as
two ongoing Biotechnology initiatives, is pleased to announce
additional features available on its e-commerce Website
(www.taurigum.com), through its
relationship with Shopify.
Enhanced features
include: Rewards Program, E-Gift Cards, Real Time Blog, Educational
Articles, and Multi-Media Customer Reviews. As a result, the
Company has already experienced a substantial increase in user
traffic on its e-commerce
site.
The Company
continues to generate strong results from its highest margin
e-commerce business segment. Additionally, the Company is excited
about providing more details soon on its two major upcoming product
launches – including the launch of its Rainbow Deluxe Sampler Pack
(exclusively through its E-Commerce
platform).
The Company has
also established E-Gift Card Denominations for Tauri-Gum™ available
through its e-commerce portal.
Tauri-Gum™ E-Gift Card
Denominations
ABOUT TAURIGA
SCIENCES INC.
Tauriga Sciences,
Inc. (TAUG) is a revenue generating, diversified life sciences
company, engaged in several major business activities and
initiatives. The company manufactures and distributes
several proprietary retail products and product lines, mainly
focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles
market segment. The main product line, branded as
Tauri-Gum™, consists of a proprietary supplement chewing gum that
is both Kosher certified and Vegan formulated (CBD Infused
Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate) & (CBG
Infused Tauri-Gum™ Flavor: Peach-Lemon). The Company’s
commercialization strategy consists of a broad array of retail
customers, distributors, and a fast-growing E-Commerce business
segment (E-Commerce website: www.taurigum.com). Please visit our
corporate website, for additional information, as well as
inquiries, at http://www.tauriga.com
Complementary to
the Company’s retail business, are its two ongoing biotechnology
initiatives. The first one relates to the development of
a Pharmaceutical grade version of Tauri-Gum™, for nausea regulation
(specifically designed to help patients that are subjected to
ongoing chemotherapy treatment). On March 18, 2020, the
Company announced that it filed a provisional U.S. patent
application covering its pharmaceutical grade version of
Tauri-Gum™. The Patent, filed with the U.S.P.T.O. is Titled
“MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS
OF TREATMENT”. The second one relates to a collaboration
agreement with Aegea Biotechnologies Inc. for the co-development of
a rapid, multiplexed, Novel Coronavirus (COVID-19) test with
superior sensitivity and
selectivity.
The Company is
headquartered in New York City and operates a regional office in
Barcelona, Spain. In addition, the Company operates a
full time E-Commerce fulfillment center located in LaGrangeville,
New York.
DISCLAIMER --
Forward-Looking Statements
This press release
contains certain “forward-looking statements” as defined by the
Private Securities Litigation Reform Act of 1995 which represent
management’s beliefs and assumptions concerning future events.
These forward-looking statements are often indicated by using words
such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,”
“believes,” or plans, and may include statements regarding
corporate objectives as well as the attainment of certain corporate
goals and milestones. Forward-looking statements are based on
present circumstances and on management’s present beliefs with
respect to events that have not occurred, that may not occur, or
that may occur with different consequences or timing than those now
assumed or anticipated. Actual results may differ materially from
those expressed in forward looking statements due to
known and unknown risks and uncertainties, such as are not
guarantees of general economic and business conditions, the ability
to successfully develop and market products, consumer and business
consumption habits, the ability to consummate successful
acquisition and licensing transactions, fluctuations in exchange
rates, and other factors over which Tauriga has little or no
control. Many of these risks and uncertainties are discussed in
greater detail in the “Risk Factors” section of Tauriga’s Form 10-K
and other filings made from time to time with the Securities and
Exchange Commission. Such forward-looking statements are made only
as of the date of this release, and Tauriga assumes no obligation
to update forward-looking statements to reflect subsequent events
or circumstances. You should not place undue reliance on these
forward-looking statements.
CONTACT:
Tauriga Sciences,
Inc.
555 Madison
Avenue, 5th Floor
New York,
NY 10022
Chief Executive
Officer
Mr. Seth M.
Shaw
Email: sshaw@tauriga.com
cell # (917) 796
9926
Instagram:
@taurigum
Twitter:
@SethMShaw
Corp.
Website: www.tauriga.com
E-Commerce
Website: www.taurigum.com
Public
Relations:
See our partner
here
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Apr 2024 to May 2024
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From May 2023 to May 2024